INtravaScular OptIcal Frequency Domain ImaGing EvaluaTion of the Femoropopliteal Lesion With JETSTREAM Atherectomy (INSIGHT JETSTREAM)
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31460 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Koji Kuroda and 10 co-authors. Institution: Department of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan. Major MEDLINE topics: Femoral Artery, Atherectomy, Vascular Calcification, Peripheral Arterial Disease. Cited 1 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
There have been no prior reports of detailed evaluations using intravascular imaging during Jetstream treatment.
Aims
This study, therefore, aimed to investigate the effects of calcification characteristics and wire bias on lumen gain in Jetstream atherectomy using optical frequency domain imaging (OFDI).
Methods
This study enrolled consecutive patients who underwent OFDI‐guided Jetstream atherectomy with 1.85 mm, 2.4 mm blade down (BD), and 2.4 mm blade up (BU). Cross‐sections were categorized into three groups based on OFDI findings before Jetstream atherectomy: fibrous plaques (FPs), calcified protrusions (CPs), and eruptive calcified nodules (ECNs).
Results
Twenty‐seven patients (36 limbs) were enrolled, and 1502 cross‐sections were serially analyzed. There were 186 FPs, 753 CPs, and 563 ECNs. The acquired lumen gain after all atherectomy steps was significantly larger in the ECNs group than in the CPs and FPs groups. ECNs had the strongest effect on the variability in the lumen gain. In the effect of wire bias on the degree of debulking, a significant correlation was observed between wire distance and lumen gain in 1.85‐ and 2.4‐mm BD atherectomy procedures. However, in the 2.4‐mm BU procedure, no significant correlation was recorded.
Conclusions
Jetstream atherectomy for ECNs can result in greater lumen gain. In the 1.85‐ and 2.4‐mm BD atherectomy procedures, wire bias may be involved in lumen gain, whereas in the 2.4‐mm BU procedure, lumen gain is obtained regardless of wire bias. In Jetstream atherectomy procedures, a detailed assessment using OFDI may contribute to predicting the degree of debulking. Trial Registration UMIN ID : UMIN000054588. https://center6.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000061997 .
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
- Division of Cardiovascular Medicine, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
- Department of Cardiology, Konan Medical Center, Kobe, Japan.
ORCID profiles: Koji Kuroda, Mayuka Masuda
Funding
- The authors received no specific funding for this work.
Cite
APA
Kuroda, K., Kozuki, A., Uzu, K., Todoroki, T., Iwasaki, M., Imanishi, J., Yamashita, S., Fujimoto, W., Takemoto, M., Masuda, M., & Okuda, M. (2025). INtravaScular OptIcal Frequency Domain ImaGing EvaluaTion of the Femoropopliteal Lesion With JETSTREAM Atherectomy (INSIGHT JETSTREAM). Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31460
Vancouver
Kuroda K, Kozuki A, Uzu K, Todoroki T, Iwasaki M, Imanishi J, et al. INtravaScular OptIcal Frequency Domain ImaGing EvaluaTion of the Femoropopliteal Lesion With JETSTREAM Atherectomy (INSIGHT JETSTREAM). Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31460
BibTeX
@article{Kuroda2025,
author = {Kuroda, Koji and Kozuki, Amane and Uzu, Kenzo and Todoroki, Takafumi and Iwasaki, Masamichi and Imanishi, Junichi and Yamashita, Souichiro and Fujimoto, Wataru and Takemoto, Makoto and Masuda, Mayuka and Okuda, Masanori},
title = {INtravaScular OptIcal Frequency Domain ImaGing EvaluaTion of the Femoropopliteal Lesion With JETSTREAM Atherectomy (INSIGHT JETSTREAM)},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31460}
}
EUVIMED